Related Experiment Video
Updated: Apr 27, 2026
Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs
Published on: March 2, 2018
[Neuroendocrine cell hyperplasia of infancy--case study]
Joanna Lange1, Megan Dishop, Katarzyna Krenke
1joanna_lange@wp.pl.
Insights
Neuroendocrine cell hyperplasia of infancy is a rare lung disease in infants. Early diagnosis relies on clinical signs, imaging, and lung tissue analysis for effective management.
Area of Science:
- Pediatric Pulmonology
- Neonatal Medicine
- Rare Diseases
Background:
- Neuroendocrine cell hyperplasia of infancy (NCH) is a rare interstitial lung disease.
- Typically diagnosed in infants and children under two years old.
Observation:
- Clinical presentation includes chest retractions, tachypnea, and hypoxemia.
- Crackles on auscultation and characteristic HRCT findings are observed.
- Histological examination of lung parenchyma is crucial for diagnosis.
Findings:
- The article details the clinical manifestations of NCH.
- A case study of an infant with this rare condition is presented.
Implications:
- Highlights the importance of recognizing NCH in infants with respiratory distress.
- Emphasizes the diagnostic value of a multidisciplinary approach.
- Contributes to understanding this rare pediatric lung disease.
Abstract:
Neuroendocrine cell hyperplasia of infancy is a rare form of children's interstitial lung disease recognised usually in infancy and in children younger than two years old. The typical clinical scenario, such as chest retractions, tachypnoea, hypoxaemia, crackles, characteristic changes in high-resolution computed tomography and histological examination of the lung parenchyma, is the cornerstone for diagnosis. In the article, the authors describe clinical manifestation of neuroendocrine cell hyperplasia and a present case of an infant with this rare interstitial lung disease.
